These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 662717)

  • 1. [Value of experimental models in the forecasting of the clinical efficacy of antineoplastic agents].
    Goldin A
    Nowotwory; 1978; 28(1):9-21. PubMed ID: 662717
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental models and their clinical correlations.
    Carter SK; Goldin A
    Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental basis of combination chemotherapy in the treatment of acute leukemia (author's transl)].
    Hoshino A
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):731-9. PubMed ID: 4480565
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M; Sakurai Y
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract]   [Full Text] [Related]  

  • 7. Some thoughts on experimental models and their clinical correlations.
    Carter SK
    Eur J Cancer (1965); 1973; 9(11-12):833-41. PubMed ID: 4804310
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of tests of chemotherapeutic agents involving repeated drug treatment.
    Ullman NS; Jacquez JA
    Biometrics; 1973 Dec; 29(4):677-93. PubMed ID: 4785233
    [No Abstract]   [Full Text] [Related]  

  • 9. Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
    Geran RI; Greenberg NH; Macdonald MM; Abbott BJ
    Natl Cancer Inst Monogr; 1977 Mar; (45):151-3. PubMed ID: 927490
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
    Venditti JM; Sheldon DR; Goldin A
    Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy in sequence for the treatment of L1210 leukemia.
    Roberts D; Hilliard SL
    Cancer Res; 1978 Aug; 38(8):2317-20. PubMed ID: 667827
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival analysis of drug combinations using a hazards model with time-dependent covariates.
    Stablein DM; Carter WH; Wampler GL
    Biometrics; 1980 Sep; 36(3):537-46. PubMed ID: 6783143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with AMSA on L1210 leukaemia and B16 melanoma.
    Dumont P; Atassi G; Tagnon HJ
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1017-21. PubMed ID: 6895729
    [No Abstract]   [Full Text] [Related]  

  • 14. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with "S" phase sensitive drugs.
    Alate AD; Khandalekar DD; Amonkar AJ; Adwankar MK; Sahasrabudhe MB
    Biomedicine; 1978 Oct; 28(5):270-3. PubMed ID: 743552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
    Momparler RL; Momparler LF; Samson J
    Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental screening of 3 forms and 19 derivatives or analogs of ellipticine: oncostatic effect on l 1210 leukaemia and immunosuppressive effect of 4 of them.
    Hayat M; Mathé G; Janot MM; Potier P; Dat-Xuong N; Cavé A; Sevenet T; Kan-Fan C; Poisson J; Miet J; Le Men J; Le Goffic F; Gouyette A; Ahond A; Dalton LK; Connors TA
    Biomedicine; 1974 Mar; 21(3):101-6. PubMed ID: 4429763
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antineoplastic activity in mice of 4,4'-(2-methyl-1,4-piperazinodiyl)bis-(4-oxo)-propenyl-1-carboxylic-1 acid diethyl ester].
    Graczyk J; Pakulska W; Groszkowski S; Najman L
    Acta Pol Pharm; 1980; 37(2):249-54. PubMed ID: 7468274
    [No Abstract]   [Full Text] [Related]  

  • 18. [Models and methods used for the selection of antitumor preparations in the USSR and abroad].
    Sof'ina ZP
    Vopr Onkol; 1976; 22(4):82-96. PubMed ID: 1274284
    [No Abstract]   [Full Text] [Related]  

  • 19. Statistical designs for experiments in combination therapy.
    Miller I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494
    [No Abstract]   [Full Text] [Related]  

  • 20. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P; Huong TH; Lhéritier J
    Bull Cancer; 1974; 61(4):509-26. PubMed ID: 4458834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.